Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
The Antimicrobial Resistance Threat: Are We Heading towards a Post-Antibiotic Era?
- Antimicrobes 2017

Report

Past Conference Report

Antimicrobes -2017

Sensing the raising global concern for Animicrobial resistance Allied academies hosted the “Annual conference on Antimicrobials and Drug Resistance” (Antimicrobes 2017), during August 23-24, 2017 in Toronto, Canada with a theme,” The Antimicrobial Resistance Threat: Are We Heading towards a Post-Antibiotic Era?”. Benevolent response and active participations were received from the Editorial Board Members as well as from the Scientists, Doctors, Researchers, Students and Leaders from the fields of AMR Research, who made this event inspiringly successful.

 The Antimicrobes 2017 Conference was carried out through various sessions with discussions on the following thought provoking and cerebrating scientific tracks:

Antimicrobials

Antimicrobial resistance

Antibacterial agents

Antimicrobial agents in food and agriculture

Viral and Bacterial Outbreaks

Industrial and Applied Microbiology

Antimicrobial agents in veterinary medicine

Antimicrobial stewardship

Public Health

The conference was initiated and embarked with an Opening Ceremony followed by a series of lectures delivered by members of the Keynote forum and Speakers. The peerless people who promulgated the theme with their exquisite talks were:

§  John J.S. Cadwell,  FiberCell Systems Inc., USA

§  Palayakotai Raghavan, Nanorx Inc, USA

§  Sasha Shafikhani, Rush University Medical Center, USA

§  John F Kokai-Kun, Synthetic Biologics, Inc., USA

§  Marc G J Feuilloley, Normandie Universite, France

§  WC Yam, The University of Hong Kong, Hong kong

Allied Academies on behalf of Organizing Committee Members, Editorial Board Members and Poster Judge congratulates the Best Poster Award for their outstanding contribution in the field of AMR and simultaneously encourage all the participants who tried to put their efforts in poster presentations and wish them success in their future research.

Best Poster Award:

Jason Asnis, University of British Columbia, Canada 

Allied Academies offers its heartfelt appreciation to Keynote speakers, Chairs, Co-chairs and the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities for supporting and making the conference a grandiose event.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Antimicrobes 2017, We are delighted to announce the next event, "2nd  Annual Conference on Antimicrobial and drug resistance” during September 24-25, 2018 in Montreal ,Canada.

Let us meet again @ Antimicrobes 2018

About

Allied Academic Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Allied Academies invites all the participants from all over the world to attend “Annual Conference on Antimicrobials and Drug Resistance” during August 23-24, 2017 in Toronto, Canada ,which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.

Antimicrobes 2017 is one of the most important microbiology conferences that bring together clinicians, researchers, and other industry professionals. The scientific program will range from “the world of microbes” to “the science of food”, to clinical, industrial, and environmental microbiology and pharmaceutical drugs. This will allow reflecting on the microbiology at 360 degrees, all-round by expanding the knowledge of everyone.

 

OUR EMINENT COLLABORATORS-


IndustryARC is the Leading Provider of Market Research Reports, Custom Consulting Services, Data Analytics and Industry Analysis. Our goal is to provide the right information required by the stakeholder at the right point of time, in a format which assists an intelligent and informed decision making process!

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

  Antimicrobes 2017 will give you the opportunity to meet the main experts around the world, present your own discovery or work, and interact with your peers. Furthermore, the stimulating scientific program will provide you to enrich professionally and socially, providing the chance to keep in touch with other participants for establishing any new future collaborations.


Mayor Greetings





Sessions/Tracks

It is our greatest pleasure to welcome you to the official website of Annual Conference on Antimicrobials and Drug Resistance, that aims at bringing together the Professors, Doctors, Researchers, Clinicians, Educators, Program developers to provide an international forum for the dissemination of original research results, new ideas and practical development experiences which concentrate on both theory and practices in our Medical meetings. The conference will be held in August 24-25, 2017 at Toronto,Canada. The theme of the conference is around,

“The Antimicrobial Resistance Threat: Are We Heading Towards a Post-Antibiotic Era?”

In line with the Annual Conference on Antimicrobials and Drug Resistance addressing the most recent advances across the spectrum of Medicine research from basic sciences to public health, conference highlights will include Antimicrobials ,Antimicrobial resistance ,Antibacterial agents, Antiviral drugs, Antifungal and Antiparasitic agents, Selective toxicity ,Antimicrobial agents in food and agriculture, Viral and Bacterial Outbreaks, Industrial and Applied Microbiology, Microbial genomics, Biomarkers in clinical research,  Antimicrobial agents in veterinary medicine,  Antimicrobial stewardship, Pharmacy and medicinal chemistry ,Public Health.

Track 1: Antimicrobials

An antimicrobial is an agent that kills microorganisms or inhibits their growth.  They are classified according to their mode of action on specific microorganism .Depending on the range of bacterial species susceptible to these agents antibacterials are classified as broad spectrum, intermediate-spectrum, or narrow- spectrum. Non–pharmaceuticals antimicrobial gives a wide range of chemical and natural compounds used as antimicrobials. Organic acids are used widely as antimicrobials in food products. The Immunology of host defence peptides gives diverse actions of HDPs.The use and misuse of antimicrobial drugs accelerates the emergence of drug-resistant strains. Post-antibiotic era refers to a time when a number of infectious diseases will be unresponsive to antibiotic treatments.

Track 2: Antimicrobial resistance

Multidrug resistant (MDR) are those microbes which are resistant to multiple antimicrobials .Resistant microorganisms (compiling fungi, bacteria, parasites and viruses) have the ability to withstand  effects of antimicrobial drugs.  Irrational use of antimicrobial drugs rapidify the origin of drug-resistant strains. Poor infection control practices, inappropriate food-handling and inadequate sanitary conditions leads to further spread of antimicrobial resistance. Diagnosis of antimicrobial drug resistance is evaluated by lab tests that makes it difficult for the the isolated microbes to grow and survive in the presence of the drug. Antimicrobial chemotherapy refers to the use of antimicrobial medicines to treat infection. Microbial immunology refers to the interrelationship among infectious agents and their hosts, with microbial and viral pathogenesis and the immunological host response to infections.

Track 3: Antibacterial agents

An antimicrobial agents are those that kills or inhibits the growth of microorganism, similarly antibacterials are effective against bacteria.. According to different groups of microorganism the action of antimicrobial medicine can be seen. Antimicrobial drugs by its mechanism of action help in treatment as well as prevention from bacterial infection .Antibiotic prophylaxis refers to the prevention of infection complications using antimicrobial therapy . Antibacterials are used to treat bacterial infections. The hazards to humans and other animals from antibacterials is generally less if compared. However, continuous use of certain antibacterials  gives side effects like it decrease the number of gut flora, which may have a bad impact on health etc.

Track 4: Antiviral drugs

Antiviral drugs are the medication used particularly for treating viral infections. Mostly antiviral drug design is to identify targets like viral proteins, or  its parts, that can be disabled. These "targets" should be as unlike parts of proteins in humans as possible, to reduce the likelihood of various possible side effects. The targets should also be common among different species of virus in the same family or across many strains of a virus, so a single drug can have broad effectiveness through its mechanism of action. Almost all anti-microbials, including anti-virals, are subject to drug resistance as these pathogenic organism mutate as time travel, resulting less susceptible to the treatment therefore  designing safe and effective antiviral drugs is difficult, because viruses always use the host's cells to replicate and increase their count.


Track 5: Antifungal and Antiparasitic agents

Antifungal and Antiparasitic are class of medication for pharmaceutical fungicide or fungistatic used to treat and prevent mycoses  and treatment of parasitic diseases, such as those caused by helminths etc ,respectively. Invasive fungal infections causes significant health problem in immune compromised patients.  So as the clinical manifestations vary and can range from colonization in allergic broncho pulmonary disease to active infection in local aetiologic agents. Therefore drug dose monitoring is necessary to ensure the therapeutic levels achieved for optimal clinical efficacy. Various Immunomodulatory properties have been identified in various antiparasitic agents and their potential therapeutic applications have been recognized. Antiparasitic resistance is the genetic ability of parasites to survive the effects of an antiparasitic drug to which they were previously susceptible. Practical and effective strategies to combat antiparasitic resistance are some what critical.

Track 6: Selective toxicity

Selective toxicity means the injuring of one kind of living matter without harming some other kind ,even though the two are in intimate contact. Toxicosis potential is usually determined more by the multitude of related factors than by actual toxicity of the toxicant. Mechanisms of staphylococcal  enterotoxin-induced emesis. Tetanospasmin  is one of the most powerful neurotoxins known. The tetanospasmin toxin is a zinc-dependent metalloproteinase others like botulinum toxin has high specificity and irreversible effects. Host cell with selective toxicity can be seen in E.coli, HIV and Influenza toxins etc. There are topical antibiotics  to deal with topical antimicrobial toxicity which are directly applied to cultured human fibroblasts  which quantitatively assess their cytotoxicity.

Track 7: Antimicrobial agents in food and agriculture

Antimicrobial agents has been used in veterinary medicine and animal husbandry veterinary medicine which has resulted in healthier and more productive farm animals,  which ensures  the health and welfare of both animals and humans. There are several  benefits of food processing  which include toxin removal, preservation, easing marketing and distribution tasks, and increasing food consistency and makes many kinds of foods safe to eat by de-activating spoilage and pathogenic micro-organisms shelf life of food product and ensure food saftey. As part of process control activities in the food manufacturing plant, antimicrobial agents have been successfully applied, both in the product formulation stage as direct food additives designed to reduce or eradicate pathogens  and benificial in antimicrobial proteins. Apart from this it has various uses in plant agriculture.

Track 8: Viral and Bacterial Outbreaks

Ebola, is a viral hemorrhagic fever of other primates and mostly humans. The Zika virus belongs to family  Flaviviridae and  genus Flavivirus, and is thus related to  many disease like dengue, yellow fever etc in one or other way .Zika is spread by the female Aedes aegypti mosquito, which is active mostly in the daytime The potential societal risk of Zika can be  restricted by delimiting the distribution of the mosquito species that transmit it. The highly pathogenic influenza A virus subtype H5N1 is an emerging avian influenza virus that is causing global concern as a potential pandemic threat. Tuberculosis  is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB). Therefore all the bacteria .and viruses Control of outbreaks requires coordinated medical services, alongside a certain level of community engagement

Track 9: Industrial and Applied Microbiology

Industrial antimicrobial agents are  the chemicals used to prevent the adverse consequences of microbiological activity in various processes and products formation. They are mainly targeted against mold,  bacteria, and fungi. There is wide range of Applications antimicrobial agents in industry. Bioremediation is a “treatment that uses naturally occurring organisms to break down intoxicated  substances into less toxic or non toxic substances .Likewise, in industrial fermentation  there is intentional use of microorganisms such as bacteria and fungi to make products useful to humans. Fermented products though have applications as food but it is also used in general industry .Along with this there are other application of microbes-powerful cleaners, agricultural improvers.

Track 10: Microbial genomics

Microbial Genomics  provide approaches to understand microbial evolution, population genomics, outbraks and epidemiological investigations, , metagenomic and whole transcriptome studies, and bioinformatic analysis, Genes and Genomes, Transcription and translational regulations  etc. A gene mutation is a permanent alteration in the DNA sequence that makes up a gene, such that this sequence is unique  in different people. Pharmacogenomics (PGx) aims to optimize drug efficacy and minimize toxicity on the basis of  improved understanding of genomic variants influence drug response. Clinical Genomics gives innovative products for colorectal cancer diagnosis. Regulation of gene expression includes a wide range of mechanisms. Genetic engineering, also called genetic modification, is the direct manipulation of an organism's genome using biotechnology futher host-microbe interactions in disease stategives the idea of pathogenomics.

Track 11: Biomarkers in clinical research

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes.( There are various types of biomarkers .) These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The incorporation of biomarker studies into early drug trials is complex. Thus the decision to proceed with studies of biomarkers should be based on balancing the strength of science, assay robustness, feasibility, and resources with the burden of proper sample collection on the patient and potential impact of the results on drug development.

Track 12: Antimicrobial agents in veterinary medicine

The use of antimicrobials in animals are closely parallels to the discovery and usage in humans.  Like  Sulfonamide was the first antimicrobial to be introduced to food animal medicine. Antibiotics are  given to food animals for growth promotion and prophylactic medication. In  other hand ,epidemiology of antimicrobial-resistant microorganisms at the human–animal interface involves complex and largely unpredictable systems that include transmission routes of resistant bacteria as well as resistance genes and the impact of antimicrobial selective pressures in several reservoir. There is an environmental impact of  Antibiotics and their metabolites (degradation products) through antibiotic-laden manure or direct deposition of manure by grazing animals.  .  Antibiotics that reach the environment ,only that proportion will remain biologically active.   Low subtherapeutic concentrations of antibiotics that accumulate over time may have profound effects on some ecosystems

Track 13: Antimicrobial stewardship

Antimicrobial stewardship  deals with well organised program that promotes the judicious use of antimicrobials (including antibiotics) , reduces microbial resistance, improves patient outcomes and decreases the spread of infections caused by multidrug-resistant organisms. Antimicrobial Stewardship influences to do safe and appropriate use of antimicrobials i.e  rationalise use of Antibiotic. Basically it emphasis more on Safety and Quality. It has research priorities like a clear research motive highlighting the most important current knowledge gaps and new data to improve future containment initiatives.

Track 14: Pharmacy and medicinal chemistry

Drug design can be defined as  the approach of finding drugs by design, based on their biological targets and the prediction of small molecules binding to it (pharmacophore, docking, QSAR,…) Antimicrobial resistance makes it harder to eliminate infections from the body as existing drugs become less effective. Metabolic engineering is the practice of optimizing genetic and regulatory processes within cells to increase the cells' production of a certain substance. Genetic engineering techniques are used to modify the network in order to relieve the constraints. Pharmaceutical formulation is a medicinal product which is formed by combination of some active drugs in different chemical substances, where the pharmaceutical drug undergo the drug development process .The global vaccine market has been established as one of the fastest growing segments of the medical and various healthcare industry.The global vaccine market is broadly analyzed on the basis of product types and antigens.

Track 15: Public Health

Public health can be summoned as "the science and art of preventing disease, promoting health and prolonging life through organized efforts in various manners and informed choices of society, organizations, public and private, communities and individuals. Here Morbidity refers to the unhealthy state of an individual, while mortality refers to the state of being mortal. Both concepts can be applied across a population or at the individual level. Where an increased in the healthcare cost is seen as the cost of drug development decreases the economic incentive to develop drugs with lower profit potentials, even those that could substantially benefit particular groups) or public health in general (eg, vaccines, antibiotics).  Thus Antimicrobials are important in Human Medicine. But there is an increasing prevalence of antimicrobial resistance and that this resistance has clinical implications, therefore a need for mitigation efforts. Including awareness on the intake of food and drugs containing antimicrobial agents.

Entrepreneur Investments Meet:   Description

A key ingredient in successful entrepreneurship is self-knowledge. (Antimicrobes 2017) aims to bring together all existing and budding bio entrepreneurs to share experiences and present innovations and challenges in microbiological community. Each year, over a million companies are started in the world with about 5–10 of them classified as high technology companies. Turning ideas into business ventures is tricky and the opportunity-recognition step is critical in new venture creation. This gestalt in the entrepreneur's perception of the relationship between the invention and final product is refined into a business model that describes how the venture will make money or provide an appropriate return to the potential investors. Biological science is complex and rapidly changing and requires a specialized knowledge to understand the value of the innovation and its competitive position in the industry. Although life scientists are typically the founders of biotech companies, studies have shown that the most successful high tech startups are founded by a team of two to three individuals with mixed backgrounds, substantial industry experience and a very clear market and product focus at founding. This three day community-wide conference will be a highly interactive forum that will bring experts in areas ranging from structural microbiology to signaling pathways to novel therapeutic approaches to the scientific hub. In addition to our outstanding speakers, we will also showcase short talks and poster presentations from submitted abstracts. The speakers will discuss how microbes can be engineered to report using computational inputs from their local environment. This session will include combined efforts of cutting edge synthetic biology research to highlight the current state, challenges and future of engineered microbial communities.


Market Analysis Report


Summary: Antimicrobes 2017 welcomes attendees, presenters, and exhibitors from all over the world to Toronto, Canada. We are delighted to invite you all to attend and register for the “Annual Conference on Antimicrobials and Drug Resistance” which is going to be held during August 23-24,2017 .The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Antimicrobes2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Antimicrobes 2017 organizing committee look forward to meet you at Toronto,Canada.

Importance and scope

An antimicrobial is an agent that kills or inhibits the growth of microorganisms. The microbial agent may be a chemical compounds and physical agents. These agents interfere with the growth and reproduction of causative organisms like bacteria, fungi, parasites, virus etc. It deals with information about antibacterial, antifungal, antiviral, Anti protozoal, anti-algal agents and their methods of detection, different therapies and advanced treatments to overcome diseases.

Antimicrobial Drugs are drug used to treat a microbial infection. Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. Examples antibiotics, antifungals, antiprotozoal, and  antiviral drugs.

Antimicrobial resistance is the developed in microbes to survive in the presence of a chemical (drug) that would normally kill them or limit their growth. Antimicrobial resistance makes it harder to eliminate infection from the body as existing drugs become less effective.

 Antimicrobial research investigates the mechanisms of action and resistance to antibiotics as well as exploring the role of antibiotic resistance in the ability of pathogenic bacteria to cause infection.

Why Toronto?

 The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.The leading players in the global antibiotics market include Pfizer Inc. (U.S.), Merck and Co. (U.S.), Eli Lilly and Co. (U.S.), Sanofi-Aventis (France), AstraZeneca (U.K.), Cubist pharmaceuticals (U.S.), Johnson & Johnson (U.S.) and GlaxoSmithKline PLC (U.K.).

The largest numbers of private hospitals are present there with proper treatment. Over one hundred physicians providing tertiary medical services in over thirty medical specialties .The Centers and hospital is equipped to deal with the most complex of conditions, including oncology, neurosurgery and cardiac surgery.

Conference highlights

  •  Antimicrobials
  • Antimicrobial resistance
  • Antibacterial agents
  • Antiviral drugs
  • Antifungal and Antiparasitic agents
  • Selective toxicity
  • Antimicrobial agents in food and agriculture
  • Viral and Bacterial Outbreaks
  • Industrial and Applied Microbiology
  • Microbial genomics
  • Biomarkers in clinical research
  • Antimicrobial agents in veterinary medicine
  • Antimicrobial stewardship
  • Pharmacy and medicinal chemistry
  • Public health

Why attend???

As mentioned earlier, Antimicrobes research, involves people from various disciplines and people form such various fields do not always get a chance to meet and discuss the current developments in their respective areas .Antimicrobes conferences seek to bring all such people together and thereby provide them a platform with which to discuss and exchange ideas with one another. The Antimicrobes conference is set to be graced by World-renowned speakers who will shed light on the most recent techniques, tactics, and the newest updates in Antimicrobials and Drug resistance Research

Market analysis

Antimicrobial additives or agents are chemical ingredients typically utilized in definite proportions to prevent fungal, bacterial and algal growth in materials exposed to high levels of moisture, ultra violet radiation or unsanitary conditions. In order to improve hygiene standards and durability of products, these additives have gained substantial traction among product manufacturers in the recent past.

Market Dynamics:

Some anti-microbial additives are hazardous to the environment when disposed. Research initiatives by environmental institutions suggest that anti-bacterial chemicals constitute significant portion of soil and water contaminants. The issue of safe disposal and harmful effects of these additives on the eco-system is identified as a restraining factor in the global anti-microbial additives market.

The antimicrobial coatings for medical devices market is segmented on the basis of type of material, device types, and regions. The global antimicrobial coatings for medical devices market is expected to grow at a CAGR of 14.2% from 2015 to 2020 to reach USD 1.17 Billion by 2020 from USD 0.61 Billion in 2015. Factors such as rising awareness about hospital-acquired infections,  favorable research and funding environment, technological advancements in antimicrobial coatings, growing implantable devices market, increasing research and development activities for antimicrobial coated cardiovascular devices, high growth in geriatric population, and increasing burden of cardiovascular diseases across the globe are driving the growth of this market

Disinfectant & Antimicrobial Chemicals to 2017 - Industry Market Research

Demand for disinfectant and antimicrobial chemicals in the US is forecast to rise 6.1 percent annually to $1.6 billion in 2017. Organosulfur compounds will see significant growth as antimicrobial agents in products such as water-based architectural paint, floor coverings, home textiles, and other construction materials.

This study analyzes the $1.2 billion US disinfectant and antimicrobial chemical industry. It presents historical demand data for 2002, 2007 and 2012, and forecasts for 2017 and 2022 by market (e.g., industrial, institutional and commercial, consumer), function (disinfectants and sanitizers, antimicrobial additives), and product (e.g., phenolics, iodophors, nitrogen compounds, organometallics, organosulfurs, aldehydes).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 20 industry players such as Dow Chemical, Lonza Group, and BASF.

Major Associations around the Globe

Danish Society for Virology

Pan American Society for Clinical Virology

International Society for Antiviral Research .

International Society for Influenza and Other Respiratory Virus Diseases

International Society for Antiviral Research

National Institute of Health(NIH)

Cancer Research

National Institute for Medical Research

French Cancer Society (SFC)

Organizations working on Antibiotics around the Globe:

Infectious Diseases Society of America

World Health Organization

U.S. Food and Drug Administration (FDA)

Center for a Livable Future (CLF)

Centers for Disease Control and Prevention (CDC)

American Medical Association

Animal Welfare Approved (AWA)

Center for Food Safety

Center for Science in the Public Interest (CSPI)

Food Animal Concern Trust (FACT)

The Humane Society of the United States (HSUS)

The Pew Charitable Trusts

Food and Water Watch

Healthy Food Action

Keep Antibiotics Working (KAW)

Natural Resources Defense Council (NRDC)

American Nurses Association

American Public Health Association

Institute of Medicine, National Academies of Science

American Society for Microbiology  


  • Antibiotic usage varies Globally

 



  • Antimicrobial-additives-market


  • Antimicrobial-surveillance of antimicrobial resistance


  • Commonly used antibiotics with there increased percentage of resistance


Organizing Committee
OCM Member
Michael Thompson
Professor
Thompson Group Bioanalytical Chemistry
Toronto, Canada
OCM Member
Terry Ann Else
Professor, Medical Microbiology/Immunology
Touro University Nevada
Las Vegas, USA
OCM Member
John J.S. Cadwell
President and CEO FiberCell Systems Inc., Pharmacology
University of Miami
Miami, USA
OCM Member
Ananda M. Chakrabarty
Professor
University of Illinois College of Medicine at Chicago
Chicago, USA
OCM Member
Debabrata Biswas
Associate Professor
University of Maryland
Baltimore, USA
OCM Member
P.R.Raghavan
CEO of nanorx inc.
New York, USA
OCM Member
Akira kaji
Professor of Microbiology , Microbiology
University of Pennsylvania
Philadelphia, USA
OCM Member
Menachem Shoham
Director, Biochemistry
Case Western Reserve University
Cleveland, USA
OCM Member
John F. Kokai-Kun
Vice President,, Non-Clinical Affairs
Synthetic Biologics, Inc.
Rockville, USA
OCM Member
Saeed El-Ashram
Associate Professor ,Kafr El-Sheikh University Egypt
Kafr El-Sheikh University Egypt
cairo, Egypt
OCM Member
Glenn S Tillotson
Senior Vice President
Cempra Pharmaceuticals
North Carolina, USA
OCM Member
Idress Hamad Attitalla
Professor, Botany Department
Omar Al-Mukhtar University
Bayda, Libya
Scientific Program
Renowned Speakers
Venue
&
Hospitality

Holiday Inn Toronto International Airport
970 Dixon Road | Toronto, ON | M9W 1J9

Ajay Tandon
Group Sales Manager
416.798.5809 - ajay.tandon@yyzia.com


Gallery

Join The Discussion

Contact Desk

Program Enquiry

Drop us an email for Program enquiry.

antimicrobes@alliedconferences.org

+1 800-858-2189

Sponsors

Sponsors Exhibiting Advertising.

antimicrobes@microbiologyconferences.org

+1 800-858-2189

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
Media Partners
Collaborations
Exhibitors

Allied Academies Global Conference Directory

Copyright © 2017-2018 Allied Academies, All Rights Reserved.